专利信息

查询条件展开筛选条件

[药品] 包含 'Olopatadine'

首页上页 1 2 3 4 5 6 7 8 9 10 下页尾页共 211 条记录, 当前第5/22页。

	公开号	公开日	申请号	申请日

首页上页 1 2 3 4 5 6 7 8 9 10 下页尾页共 211 条记录, 当前第5/22页。

当前查询条件: [药品] 包含 'Olopatadine'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. US2012295967A1	2012/11/22	US201213475607	2012/5/18
专利标题：HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION 专利权人：GAMACHE DANIEL A [US];ALANI LAMAN [US];GHOSH MALAY [US];GALAN FRANCISCO JAVIER [ES];PERDIGUER NURIA CARRERAS [ES];SINGH ONKAR N [US]; The present invention is an ophthalmic composition containing a relatively high concentration of olopatadine. The composition is typically an ophthalmic aqueous solution containing relatively high concentrations of olopatadine solubilized within the solution. The composition is preferably capable of providing enhanced relief from symptoms of ocular allergic conjunctivitis, particularly late phase symptoms of ocular allergic conjunctivitis.

2. US20120295967A1	2012/11/22	US13/475607	2012/5/18
专利标题：High concentration olopatadine ophthalmic composition 专利权人：Alcon Research, Ltd.; The present invention is an ophthalmic composition containing a relatively high concentration of olopatadine. The composition is typically an ophthalmic aqueous solution containing relatively high concentrations of olopatadine solubilized within the solution. The composition is preferably capable of providing enhanced relief from symptoms of ocular allergic conjunctivitis particularly late phase symptoms of ocular allergic conjunctivitis.

3. WO2012159064A1	2012/11/22	WO2012US38663	2012/5/18
专利标题：High concentration olopatadine ophthalmic composition 专利权人：Alcon Research, Ltd.; The present invention is an ophthalmic composition containing a relatively high concentration of olopatadine. The composition is typically an ophthalmic aqueous solution containing relatively high concentrations of olopatadine solubilized within the solution. The composition is preferably capable of providing enhanced relief from symptoms of ocular allergic conjunctivitis particularly late phase symptoms of ocular allergic conjunctivitis.

4. JP2012524740A	2012/10/18	JP20120506423	2010/3/23
专利标题：Production method of [oropatajin] 专利权人： A process for the preparation of olopatadine hydrochloride starting from an advanced intermediate.

5. AU2007346121B2	2012/8/23	AU20070346121	2007/2/7
专利标题：Olopatadine formulations for topical nasal administration 专利权人：Alcon, Inc.; Topical formulations of olopatadine for treatment of allergic or inflammatory disorders of the nose are disclosed. The aqueous formulations contain approximately 0.6 % (w/v) of olopatadine.

6. KR20120091037A	2012/8/17	KR20127008229	2010/10/1
专利标题：Olopatadine compositions and uses thereof 专利权人：Alcon Research, Ltd.;

7. EP2482798A1	2012/8/8	EP20100762842	2010/10/1
专利标题：Olopatadine compositions and uses thereof 专利权人：Alcon Research, Ltd.;

8. JP2012516869A	2012/7/26	JP20110548657	2010/2/1
专利标题：[oropatajin] and/or that production method of the salt which can be allowed pharmacy 专利权人： The present invention relates to a process for the preparation of olopatadine and more particularly to an improved method of synthesizing olopatadine which comprises reacting a dibenz[be]oxepin-11-one derivative of formula (III) and a suitable reagent under Witting condition and to the intermediate 11-[(Z)-3-(dimethylamino)-propylidene]-6-11-dihydrodibenz[be]-oxepin-2-acet-amide p-toluensulfonate salt.(From US2012016138 A1)

9. CN101695480B	2012/7/25	CN20091172981	2009/9/15
专利标题：Olopatadine hydrochloride dispersible tablets and preparation method thereof and detection method 专利权人：Beijing Sihuan Kebao Pharmaceutical Co., Ltd.;

10. CN102548536A	2012/7/4	CN20108043493	2010/10/1
专利标题：The olopatadine composition and use thereof 专利权人：Alcon Res Ltd.;

下载范围

下载内容